Keyphrases
Placenta
66%
Antidepressant Treatment
50%
Social Behavior
50%
During Pregnancy
43%
Antidepressants
43%
Selective Serotonin Reuptake Inhibitors
41%
Pregnant Women
33%
Serotonin Level
28%
Maternal Depression
27%
Treatment during Pregnancy
27%
Live Fish
25%
Maternal Environment
25%
Villous Tissue
25%
Depression Treatment
25%
Sex Differences
25%
Perinatal Depression
25%
Serotonin Reuptake Inhibitor Antidepressants
25%
Maternal Antidepressant
25%
Sex-specific
25%
Transcriptomic Changes
25%
Fluoxetine
23%
Fetus
18%
Behavioral Health
16%
Behavioral Development
16%
Developing child
16%
Serotonin
12%
Adverse Effects
9%
Inhibitor Treatment
9%
Male Infant
9%
Autistic Traits
8%
Depressive Symptoms
8%
Autism Spectrum Disorder
8%
Gene Expression
8%
Early Life Stress
8%
Differentially Expressed Genes
8%
Drug Use in Pregnancy
8%
Antidepressant Exposure
8%
Social Disorder
8%
Transporter Expression
8%
High Risk
8%
Autism
8%
Depressive Symptoms during Pregnancy
8%
Serotonin Transporter
8%
Major Depressive Disorder
8%
Rat Offspring
8%
Exposure during Pregnancy
8%
Female Infant
6%
Neuroscience
Social Behavior
100%
Antidepressant
80%
Selective Serotonin Reuptake Inhibitor
65%
Fluoxetine
34%
Postpartum Depression
29%
Serotonin Transporter
26%
Serotonin Reuptake Inhibitor
25%
Transcriptomics
25%
Antenatal Depression
23%
Pervasive Developmental Disorder
20%
Serotonin
18%
Depression
9%
Ultrasonic Vocalization
6%
Adverse Effect
6%
Major Depressive Disorder
5%
Pharmacology, Toxicology and Pharmaceutical Science
Antidepressant
59%
Selective Serotonin Reuptake Inhibitor
54%
Serotonin
43%
Fluoxetine
34%
Prenatal Exposure
25%
Serotonin Reuptake Inhibitor
25%
Antenatal Depression
23%
Adverse Event
16%
Autism
7%
Transcriptome
6%
